-
1
Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers
Published 2024-12-01Subjects: Get full text
Article -
2
The novel CD16A/anti-CD3 bifunctional protein, eCD16A/anti-CD3-BFP, redirects T cell cytotoxicity toward antibody-bound target cells
Published 2025-12-01Subjects: Get full text
Article -
3
Natural killer cell engagers for cancer immunotherapy
Published 2025-01-01Subjects: Get full text
Article